Page last updated: 2024-10-26

erythrosine and Cardiac Hypertrophy

erythrosine has been researched along with Cardiac Hypertrophy in 2 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kilić, A1
Javadov, S1
Karmazyn, M1
Harrison, BC1
Roberts, CR1
Hood, DB1
Sweeney, M1
Gould, JM1
Bush, EW1
McKinsey, TA1

Other Studies

2 other studies available for erythrosine and Cardiac Hypertrophy

ArticleYear
Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
    Journal of molecular and cellular cardiology, 2009, Volume: 46, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Dose-R

2009
The CRM1 nuclear export receptor controls pathological cardiac gene expression.
    Molecular and cellular biology, 2004, Volume: 24, Issue:24

    Topics: Adenoviridae; Adenylate Kinase; Adhesins, Bacterial; Animals; Animals, Newborn; Antibodies, Monoclon

2004